82822:HK:HK- (CNY)

ETF | Others |

Last Closing

USD 11.23

Change

+0.55 (+5.15)%

Market Cap

USD 8.59B

Volume

1.48M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

-0.42 (-1.93%)

USD 159.33B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-2.18 (-2.67%)

USD 30.56B
2801:HK iShares Core MSCI China ETF

-0.64 (-2.90%)

USD 22.44B
2823:HK iShares FTSE A50 China

-0.04 (-0.30%)

USD 17.65B
83188:HK ChinaAMC CSI 300 Index ETF

+0.02 (+0.05%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

-0.07 (-4.90%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

-0.40 (-3.82%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

-0.10 (-1.45%)

USD 3.03B
9846:HK iShares Core CSI 300

-0.01 (-0.29%)

USD 2.96B

ETFs Containing 82822:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.65% 50% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.65% 50% F 50% F
Trailing 12 Months  
Capital Gain 3.60% 62% D 63% D
Dividend Return 2.95% 42% F 24% F
Total Return 6.55% 66% D+ 63% D
Trailing 5 Years  
Capital Gain -8.40% 44% F 68% D+
Dividend Return 12.72% 73% C 34% F
Total Return 4.32% 55% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain -5.49% 43% F 44% F
Dividend Return -3.26% 49% F 45% F
Total Return 2.23% 65% D 44% F
Risk Return Profile  
Volatility (Standard Deviation) 14.20% 71% C- 89% A-
Risk Adjusted Return -22.96% 47% F 39% F
Market Capitalization 8.59B 73% C 81% B-

Annual Financials (CNY)

Quarterly Financials (CNY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.